17947/34347US=60 / Biol/Mol
Karam JA, Hsieh JT. Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 25-50. ISBN 978-1-4020-9596-2.

APOPTOSE; AUTOFAGIA; CANCER DE BEXIGA; NECROSE; MORTE CELULAR PROGRAMADA; VIAS DE SINALIZACAO

17948/34347US=60 / Biol/Mol
Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV)

17949/34347US=50 / Câncer
Schadendorf D. Pegylated interferons in the adjuvant treatment of melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 555-64. ISBN 978-1-60327-086-1.

TRATAMENTO ADJUVANTE DO MELANOMA. INTERFERON PEGUILADO; INTERFERON PEGUILADO; SOBREVIDA LIVRE DE RECIDIVA; SOBREVIDA GLOBAL; MELANOMA; EFEITOS IFN; AJCC ESTAGIO III

17950/34347US=60 / Biol/Mol
Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA

17951/34347US=50 / Câncer
Hauschild A, Kahler KC, Egberts F. Sorafenib, a multikinase inhibitor: results from clinical trials in melanoma patients. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 565-74. ISBN 978-1-60327-086-1.

SORAFENIB. INIBIDOR MULTIQUINASE; PACIENTES COM MELANOMA; MELANOMA; METASTASE; SORAFENIB; INIBIDORES MULTIQUINASE

17952/34347US=50 / Câncer
Chmielowski B, Ribas A. Targeting immunological synapse: new horizons in immunotherapy for cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 575-90. ISBN 978-1-60327-086-1.

SEGMENTACAO SINAPSE IMUNOLOGICA; IMUNOTERAPIA PARA O CANCER; IMUNOTERAPIA; SINAPSE IMUNOLOGICA; CTLA-4; AUTO-IMUNIDADE; MELANOMA; CANCER

17953/34347US=50 / Câncer
Garbe C, Weide B, Pflugfelder A, Eigentler T. Cutaneous metastases of melanoma: new treatment options. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 591-8. ISBN 978-1-60327-086-1.

METASTASES CUTANEAS DE MELANOMA. TRATAMENTO; MELANOMA; METASTASES CUTANEAS; INTERLEUCINA-2; IMIQUIMOD; BLEOMYCINE; TRATAMENTO INTRATUMORAL

17954/34347US=50 / Câncer
Tarhini AA, Kirkwood JM. Neoadjuvant approaches in melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 599-605. ISBN 978-1-60327-086-1.

NEO-ADJUVANTE EM MELANOMA; MELANOMA; NEOADJUVANTE; INTERFERON; IMUNOTERAPIA

17955/34347US=50 / Câncer
Agarwala SS. Implications of chemo/biochemotherapy in the treatment of metastatic melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 607-9. ISBN 978-1-60327-086-1.

QUIMIO/BIOQUIMIOTERAPIA. TRATAMENTO DO MELANOMA; IMUNOTERAPIA; QUIMIOTERAPIA; BIOQUIMIOTERAPIA; MELANOMA METASTATICO

17956/34347US=60 / Biol/Mol
Nicholl MB, Hoon DSB. Apoptosis in cutaneous melanoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 111-25. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; MELANOMA CUTANEO; APAF-1; SURVIVINA; INIBIDORES DE APOPTOSE

17957/34347US=60 / Biol/Mol
Li Y, Martin RCG. Apoptosis in carcinogenesis and chemotherapy - esophageal cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 127-56. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; QUIMIOTERAPIA; CANCER DE ESOFAGO; VIAS DE SINALIZACAO; CARCINOMA ESOFAGICO; ADENOCARCINOMA ESOFAGICO

17958/34347US=60 / Biol/Mol
Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS

17959/34347US=60 / Biol/Mol
Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR

17960/34347US=60 / Biol/Mol
Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE

17961/34347US=60 / Biol/Mol
Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA

17962/34347US=60 / Biol/Mol
Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA

17963/34347US=60 / Biol/Mol
Lee MH, Yang H, Zhao R, Yeung SCJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 273-94. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER NASOFARINGEO; REGULADORES DE CRESCIMENTO; CICLO CECLULAR; CARCINOMA NASOFARINGEO; SINALIZACAO DE TRANSDUCAO; REGULADORES DE CRESCIMENTO NEGATIVO; REGULADORES DE CRESCIMENTO POSITIVO

17964/34347US=60 / Biol/Mol
Alin N, MacLeod S, Hine RJ, Chowdhury P. Cellular signaling mechanisms in pancreatic apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 295-325. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; MECANISMOS DE SINALIZACAO DE APOPTOSE; FOSFATOS DE INOSITOL; NUTRICAO; CARCINOGENESE PANCREATICA; CANCER DE PANCREAS; BIOMARCADORES; INIBIDORES DE CASPASES; FAMILIA IAP; MECANISMOS ACOPLADOS A PROTEINA- G; POLIFOSFATOS DE INOSITOL; BIOMARCADORES; DIETA; ESTRESSE OXIDATIVO

17965/34347US=60 / Biol/Mol
Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO

17966/34347US=60 / Biol/Mol
Liu ZM, Chen GG. Carcinogenesis and therapeutic strategies for thyroid cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 347-74. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; CANCER DA TIREOIDE; TERAPIA ANTI-CANCER; ANGIOGENESE

Primeira | Anterior | Próxima | Última